Robotic retinal camera and remote grading for primary care
Raised to date
$7.5M
of $13M offered across 1 Form D filing
Optain Health sells a retinal screening service built on Resolve, an FDA 510(k)-cleared portable robotic camera that captures retinal images without pupil dilation. Images are graded remotely by eye specialists with AI support for diabetic retinopathy, glaucoma and macular degeneration, and the platform also estimates cardiovascular risk. It acquired the EyePACS teleophthalmology network and integrates with major US EHRs, selling to health systems, primary care practices, health plans and FQHCs.
Push-button robotic retinal capture that non-specialist staff can run, paired with specialist multi-condition grading and EHR-ready, ICD-10-coded reports.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Oct 13, 2026 | Equity | $7.5M/ $13M | Form D |
Medical imaging device and teleophthalmology service
FDA-cleared portable robotic retinal camera used with remote specialist grading of the images.
Built for
Health systems, primary care practices, health plans, at-home care providers and FQHCs
